Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School,Boston, MA 02114;
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School,Boston, MA 02114;
Department of Immunology and Cell Biology, Research Center Borstel, D-23845 Borstel,Germany;
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School,Boston, MA 02114;
nanotechnology; ovarian cancer; proliferative index; photodynamic therapy; antibodv;
机译:通过膜受体EGFR和核蛋白Ki-67双重靶向增殖肿瘤细胞后的光控开关
机译:通过膜受体EGFR和核蛋白Ki-67双重靶向增殖肿瘤细胞后的光控开关
机译:β半乳糖苷结合蛋白细胞因子靶向磷酸肌醇3激酶可否定akt基因表达并导致侵袭性乳腺癌细胞凋亡性死亡
机译:使用Theranostic脂质体的Ki-67蛋白的靶向灭活导致增殖细胞的死亡
机译:细胞死亡,生长停滞,增殖恢复和DNA损伤修复是乳腺肿瘤细胞中对电离辐射的响应的组成部分。
机译:通过膜受体EGFR和核蛋白Ki-67双重靶向增殖肿瘤细胞后的光控开关
机译:β半乳糖苷结合蛋白细胞因子靶向磷酸肌醇3激酶可否定akt基因表达并导致侵袭性乳腺癌细胞凋亡性死亡